UCSF collaborates to measure opioid use disorder treatment in local population

San Francisco officials are taking significant steps to address the opioid crisis in the city, as discussions during a recent government meeting highlighted the need for better data on medication-assisted treatment for opioid use disorder. Currently, there are approximately 5,000 individuals receiving methadone treatment, but city leaders acknowledge the lack of clarity regarding the total number of residents affected by opioid addiction.

Dr. Colfax, a key figure in the city's health department, emphasized the importance of establishing a clear denominator—essentially, the total number of people in San Francisco with opioid use disorder. This data is crucial for understanding how many individuals are receiving appropriate treatment, such as methadone or buprenorphine. To address this gap, the city is collaborating with the University of California, San Francisco (UCSF) to calculate these figures, which will help set measurable goals for treatment expansion.

The meeting underscored the lessons learned from the HIV care model, where tracking patient numbers has been vital for improving health outcomes. City officials are hopeful that similar strategies can be applied to substance use treatment, allowing for a more effective response to the ongoing crisis.

As San Francisco moves forward with this initiative, the focus remains on enhancing access to treatment and ultimately improving the health and well-being of those struggling with opioid addiction. The collaboration with UCSF is expected to yield valuable insights that will guide future efforts in combating this public health challenge.